On October 22, Microsoft published MAI-DxO research in Science and open-sourced SDBench. Using multi-agent collaboration, MAI-DxO achieved 83.2% diagnostic accuracy on 304 complex NEJM cases (vs. 36.1% for doctors) and 80.3% on 325 emergency cases (vs. 46.8%).
Today, Baba raised a $40M Series A.
We give each Medicare member and their family a dedicated team of advocates and behavioral health experts to keep every part of their care moving forward. In a world obsessed with AI personal assistants, it’s never been more important to have expert humans in the loop to go the last mile, particularly in healthcare.
Our advocates have moved mountains for their patients - finding safe housing for the near-homeless, recertifying Medicaid for those about to lose their benefits, and getting financial assistance for people cutting their pills to afford groceries.
In the process, we’ve used AI to scale the impact this special team can have. And to truly teach AI to reason and execute like the best care coordinators, we’ve built the largest learning environment for the type of work that we do everyday.
There is still a lot to do: we’ve served fewer than 1% of the 70 million Americans on Medicare.
Baba does not lack capital or customer demand. Our ability to seize this opportunity is now limited by the capacity of our team. If you’re an exceptional engineer or operator in New York, come build with us: https://t.co/iNUpe3Zd6U.
Our Series A was led by @FirstMarkCap , with @CVSHealth, @valtruis, @generalcatalyst, @geniusventures, and @GroundUpVC investing alongside them.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
https://t.co/vi51OhznQn
OpenAI acquired Torch, a healthcare data company, in January; launched GPT-Rosalind, a life sciences model, in April; and acquired Orchestra Bio in October, marking AI's entry into drug development.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
https://t.co/vi51OhznQn
@jselanikio@OpenAI@advocatehealth@becker sad to hear from you. AI company is becoming a giant monster to be a Entrance, encroaching on the medical and health market
Incredibly, hospitals are now paying for AI companies to disrupt them. 🤦♂️
Patients linking their MyChart accounts to @OpenAI's ChatGPT rose more than 7,000% in a single month at 69-hospital @AdvocateHealth, its CIO Bobbie Byrne told @Becker’sHR.
Patients set this up themselves in ChatGPT, so that the AI can explain their lab results, scans, and doctors’ notes. You know, instead of one of Advocate's doctors.
To add insult to disruption, every time a patient asks ChatGPT a question, Advocate’s Epic system has to look up and send the records and pay for the computing resources that make that happen. AND — brace yourself — Federal law says Advocate can't charge patients, or their apps, for that access to the patient's own records.
So a health system is paying for a competitor’s access to its own patients’ records. The competitor takes away the followup visit, and the healthcare system pays for that to happen — both in lost revenue and in increased computing costs.
That’s Interpretation Migration, subsidized by the disruptee. https://t.co/GTj7Hzfd1d #DrYou #InterpretationMigration #Disruption
@Berci On October 15, JAMA published a study on the real use of OpenEvidence: From January 2024 to June 2026, about 952,000 American clinical professionals submitted a total of 271 million queries. Among inquiries, treatment and management accounted for 33.1%, and diagnosis for 13.9%.
On October 15, JAMA published a study on the real use of OpenEvidence: From January 2024 to June 2026, about 952,000 American clinical professionals submitted a total of 271 million queries. Among inquiries, treatment and management accounted for 33.1%, and diagnosis for 13.9%.
"A growing share of knowledge access is shifting from recall to retrieval." Clinical judgment stays with the doctor.
From a Harvard-led JAMA study, co-authored with OpenEvidence researchers.
Clinicians bring OpenEvidence the question that matters most once a diagnosis is made: what to do next for this patient.
New in @JAMA_current, from researchers at Harvard Medical School and OpenEvidence, including our CMO @TravisZack2: treatment and management questions outnumbered diagnosis questions more than two to one.
That should change how clinical AI gets tested. Most evaluations still grade diagnosis with board-style vignettes that have one right answer. Real treatment questions rarely do. They depend on this patient's kidneys and on the trial that changed practice last spring. That is the test we want to be held to.
Physicians also reached well beyond their own fields. ER doctors asked about topics outside emergency medicine 88% of the time. Medicine is wider than any one specialty, and good clinicians check before they act.
Baba's website is great. Everyone should have a look! It clearly and intuitively reflects the dilemma of medical care! And baba's distinctive demand response plan
@BabaHQ
Everyone’s chatbot can book a doctor’s appointment.
The real test is whether you can earn the trust of a Spanish-speaking diabetic woman, walk her through a Medicaid application while finding her secure housing, and coach her into choosing a 12oz (instead of 16oz) soda along the way.
Today we’re sharing BabaBench, a benchmark measuring how frontier models perform the real work of healthcare coordination. Our synthetic worlds are built from annotations by Baba’s in-house team of hundreds of expert doctors, therapists, nurses, and social workers.
Turns out, AI alone isn’t ready to replace human care coordination.
@BabaHQ Baba's website is great. Everyone should have a look! It clearly and intuitively reflects the dilemma of medical care! And baba's distinctive demand response plan
Everyone’s chatbot can book a doctor’s appointment.
The real test is whether you can earn the trust of a Spanish-speaking diabetic woman, walk her through a Medicaid application while finding her secure housing, and coach her into choosing a 12oz (instead of 16oz) soda along the way.
Today we’re sharing BabaBench, a benchmark measuring how frontier models perform the real work of healthcare coordination. Our synthetic worlds are built from annotations by Baba’s in-house team of hundreds of expert doctors, therapists, nurses, and social workers.
Turns out, AI alone isn’t ready to replace human care coordination.
Johns Hopkins established the model for American medical education more than a century ago. Today @HopkinsMedicine and OpenEvidence announced a collaboration to define what that education should look like in the AI era, and to ground clinical care in the latest evidence.
As AI learns to synthesize the world's medical knowledge in seconds, the clinician's role moves toward clinical judgment, first-principles reasoning, and the human work of caring for patients. The education model Johns Hopkins and OpenEvidence will design builds on those foundations, with a deeper grounding in pathophysiology and evidence-based medicine. Knowing why an ACE inhibitor works is understanding a physician carries through an entire career.
Together we'll also build human-first AI that puts the best available evidence in the context of each patient's medical history and Johns Hopkins' best practices, so clinicians can reason through that information faster and make the best decision for their patient.
Sanjay Desai, Vice Dean for Education at Johns Hopkins Medicine, says AI "invites us back to the bedside."
For the educators here: which skills do you want every trainee to keep sharp?
@cristinatejerap@NEJM Los estudiantes, incluidos los profesores, pueden aprender recetas mecánicas convencionales, pero la IA puede romper los límites de conocimiento de múltiples especialidades y proporcionar un diagnóstico más completo y basado en la evidencia.